Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick G Hayden

Showing results (21-30 of 157) with videos related to

Pageof 16
Sort By:
The Journal of Infectious Diseases|October 16, 2025
Introduction and Update: Advances in Influenza TherapeuticsFrederick G Hayden, Richard J Whitley
The Journal of Infectious Diseases|January 25, 2020
Respiratory Syncytial Virus Antivirals: Problems and ProgressFrederick G Hayden, Richard J Whitley
Lancet (London, England)|July 2, 2013
Oseltamivir resistance during treatment of H7N9 infectionAlan J Hay, Frederick G Hayden
The Journal of Infectious Diseases|June 16, 2007
John F. Enders lecture 2006: antivirals for influenzaAdrian K Ong, Frederick G Hayden
American Journal of Respiratory and Critical Care Medicine|November 3, 2012
Rhinovirus genetics and virulence: looking for needles in a haystackFrederick G Hayden, Ronald B Turner
Antiviral Therapy|February 8, 2012
Spotlight on respiratory viruses 2012: introductionMenno D de Jong, Frederick G Hayden
The Journal of Infectious Diseases|July 1, 2009
"Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse eventsDavid Evans, Simon Cauchemez, Frederick G Hayden
The Journal of Infectious Diseases|December 15, 2010
Emerging influenza antiviral resistance threatsFrederick G Hayden, Menno D de Jong
Influenza and Other Respiratory Viruses|August 19, 2011
Report of the 'mechanisms of lung injury and immunomodulator interventions in influenza' workshop, 21 March 2010, Ventura, California, USAWendy A Howard, Malik Peiris, Frederick G Hayden
The Journal of Infectious Diseases|March 27, 2012
Combination antiviral therapy for influenza: predictions from modeling of human infectionsAlan S Perelson, Libin Rong, Frederick G Hayden
Pageof 16

Showing results (21-30 of 157) with videos related to

Sort By:
Pageof 16
The Journal of Infectious Diseases|October 16, 2025
Introduction and Update: Advances in Influenza TherapeuticsFrederick G Hayden, Richard J Whitley
The Journal of Infectious Diseases|January 25, 2020
Respiratory Syncytial Virus Antivirals: Problems and ProgressFrederick G Hayden, Richard J Whitley
Lancet (London, England)|July 2, 2013
Oseltamivir resistance during treatment of H7N9 infectionAlan J Hay, Frederick G Hayden
The Journal of Infectious Diseases|June 16, 2007
John F. Enders lecture 2006: antivirals for influenzaAdrian K Ong, Frederick G Hayden
American Journal of Respiratory and Critical Care Medicine|November 3, 2012
Rhinovirus genetics and virulence: looking for needles in a haystackFrederick G Hayden, Ronald B Turner
Antiviral Therapy|February 8, 2012
Spotlight on respiratory viruses 2012: introductionMenno D de Jong, Frederick G Hayden
The Journal of Infectious Diseases|July 1, 2009
"Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse eventsDavid Evans, Simon Cauchemez, Frederick G Hayden
The Journal of Infectious Diseases|December 15, 2010
Emerging influenza antiviral resistance threatsFrederick G Hayden, Menno D de Jong
Influenza and Other Respiratory Viruses|August 19, 2011
Report of the 'mechanisms of lung injury and immunomodulator interventions in influenza' workshop, 21 March 2010, Ventura, California, USAWendy A Howard, Malik Peiris, Frederick G Hayden
The Journal of Infectious Diseases|March 27, 2012
Combination antiviral therapy for influenza: predictions from modeling of human infectionsAlan S Perelson, Libin Rong, Frederick G Hayden
Pageof 16